Publications by authors named "Gabriele Sutter"

Claim this Profile
P
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function: A Comprehensive Investigation Using Clinical Trial Data, Modeling and Simulation, and In Vitro Data.
Tommaso Fadini, Gabriele Sutter, Stefan Klein, Eva Busemann, Esmée Vendel

Invest Radiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of the novel tetrameric gadolinium-based MRI contrast agent gadoquatrane in healthy Chinese and Japanese men: Two randomized dose-escalation studies including concentration-QTc modeling.
Xuemei He, Shunji Matsuki, Kexin Li, Yubin Sui, Kumi Matsuno, Gabriele Sutter

Eur J Pharm Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults.
Birte Maria Hofmann, Kai Riecke, Stefan Klein, Matthias Berse, Antje Rottmann, Gabriele Sutter

Invest Radiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease.
Ibrahim Ince, Klaas Prins, Stefan Willmann, Gabriele Sutter, Eva Hanze

J Clin Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure-response modelling and simulation.
Gabriele Sutter, Matthias Frei, Marcus-Hillert Schultze-Mosgau, Kathrin Petersdorf, Christian Seitz

Br J Clin Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin.
Stefan Willmann, Matthias Frei, Gabriele Sutter, Katrin Coboeken, Thomas Wendl

CPT Pharmacometrics Syst Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations.
Christian Kunze, Hans-Joachim Mentzel, Rajesh Krishnamurthy, Robert Fleck, Martin Stenzel, Gabriele Sutter

Invest Radiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms.
Gabriele Sutter, Thomas Schmelter, Kerstin Gude, Matthias Schaefers, Christoph Gerlinger

Menopause· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From adults to children: simulation-based choice of an appropriate sparse-sampling schedule.
Stefanie Reif, Marcus Schultze-Mosgau, Gabriele Sutter

Paediatr Drugs· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP).
Alexander Huppertz, Josy Breuer, Lueder M Fels, Marcus Schultze-Mosgau, Gabriele Sutter

J Magn Reson Imaging· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis